Delivery Order SPE2DB20D1100-SPE2DB25FE5A2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,652.07 to AmerisourceBergen Drug Corp for the supply of Cyclosporine 0.05% Eye Emulsion (60 units) with an ultimate completion date of October 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Cyclosporine 0.05% eye emulsion in 30-unit quantities, with a ceiling value of $6,777.94 and completion target of October 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves...
- The Defense Logistics Agency awarded a delivery order valued at $9,160.01 to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Cyclosporine 0.05% eye emulsion (60 units). This firm fixed-price delivery order, with an ultimate completion date of November 7, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $20,448.66 to AmerisourceBergen Drug Corp for the supply of Cyclosporine 0.05% Eye Emulsion (30-count units) on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The contract represents a child order under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Cyclosporine 0.05% eye emulsion in 30-count packages. The $1,107.10 contract has a completion date of February 20, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,176.24, is a delivery order for the supply of Cyclosporine 0.05% eye emulsion, a pharmaceutical product. The contract is not designated as a set-aside and is a firm fixed-price arrangement. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract worth $8,357.70 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of Cyclosporine 0.05% Eye Emulsion, a specialty pharmaceutical product. This delivery order is issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,324.86 firm fixed price contract is for the supply of Cyclosporine 0.05% eye emulsion, a pharmaceutical product. The contract has an ultimate completion date of August 27, 2024. Amerisourcebergen is one of the largest pharmaceutical distributors in the United States and has been awarded numerous federal contracts by various defense and civilian agencies...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for CYCLOSPORINE 0.05% EYE EMULS 60S. The delivery order has a potential value of $7,335.36 and a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and serves as a supplier of pharmaceuticals and medical supplies to U.S. government agencies, particularly the Department of Defense. The contract does...
- The Defense Logistics Agency awarded a $2,777.72 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion (30 count) under a firm fixed price contract structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract involves no set-aside designation and was...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE5A2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,510.53 to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion (60 units) with a firm fixed price structure and an ultimate completion date of September 8, 2025. This non-set-aside, competitively awarded delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains through open competition, with delivery orders typically structured as firm fixed price arrangements. The pharmaceutical supplier maintains significant scale in federal contracting, regularly fulfilling orders from less than $100 to exceeding $45,000 as part of its role within the DLA's Medical Supply Chain network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/5/25 |